Rafferty Asset Management
KZR

Rafferty Asset Management’s Kezar Life Sciences KZR Stock Holding History

Rafferty Asset Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24,912
Closed -$780K – 1118
2023
Q1 		$780K Sell
24,912
-9,963
-29% -$576K 0.01% 855
2022
Q4 		$2.46M Buy
34,875
+10,416
+43% +$772K 0.02% 519
2022
Q3 		$2.11M Buy
+24,459
New +$2.38M 0.02% 499
2022
Q2 		– Sell
-13,735
Closed -$2.28M – 1181
2022
Q1 		$2.28M Buy
13,735
+6,953
+103% +$998K 0.01% 564
2021
Q4 		$1.13M Buy
+6,782
New +$766K 0.01% 814

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Rafferty Asset Management's KZR Position: Q2 2023 in Review

Rafferty Asset Management sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 24,912 shares — an estimated $780K sold.

Rafferty Asset Management first reported a position in KZR in Q4 2021 and held it in 5 quarters. The position peaked at $2.46M in Q4 2022. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Rafferty Asset Management reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 24,912 Kezar Life Sciences shares in Q2 2023, an estimated $780K.
  • Rafferty Asset Management first reported a position in Kezar Life Sciences in Q4 2021 and held it in 5 quarters.
  • Rafferty Asset Management's Kezar Life Sciences position peaked at $2.46M in Q4 2022.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.